Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 2—February 2022
Dispatch

Neisseria gonorrhoeae FC428 Subclone, Vietnam, 2019–2020

Trang Minh Trinh1, Tam Thi Nguyen1Comments to Author , Thanh Viet Le, Trang Thu NguyenComments to Author , Dan Thi Ninh, Bao Hac Duong, Minh Van Nguyen, Thomas Kesteman, Lan Thi Pham, and H. Rogier van Doorn
Author affiliations: National Hospital of Dermatology and Venereology, Hanoi, Vietnam (T.M. Trinh, L.T. Pham); Hanoi Medical University, Hanoi (T.M. Trinh, L.T. Pham); Oxford University Clinical Research Unit, Hanoi (T. Thi Nguyen, T. Thu Nguyen, T. Kesteman, H.R. van Doorn); Quadram Institute Bioscience, Norfolk, UK (T.V. Le); Hospital of Dermatology and Venereology, Ho Chi Minh City, Vietnam (B.H. Duong); Hospital of Dermatology and Venereology, Da Nang City, Vietnam (M.V. Nguyen); University of Oxford, Oxford, UK (T. Kesteman, H.R. van Doorn)

Main Article

Table

Epidemiologic and clinical characteristics of patients infected with multidrug-resistant Neisseria gonorrhoeae ST13871, Vietnam, 2019–2020*

Variable
 No. (%)
Patient sex
M 13 (87)
F
 2 (13)
Place of consultation, year
Ho Chi Minh City, 2019 3 (20)
Ho Chi Minh City, 2020 9 (60)
Danang, 2020 3 (20)
Hanoi
 0
Clinical history
Previous STIs 0
Co-infection with other STIs
Syphilis 0
    Chlamydia trachomatis
 0
Sexual history
Sex partners during past 3 mo
1 10 (67)
    >2 5 (33)
Sexual contact with commercial sex worker 5 (33)
Unprotected sex during most recent intercourse 12 (80)
Men who have sex with men
0
Current treatment with antibiotic 15 (100)
    Ceftriaxone, 1g intramuscularly 15 (100)
    Azithromycin, 1g orally 10 (67)

*Patient age range (median) 19–56 (31) y. ST, sequence type; STIs, sexually transmitted infections.

Main Article

1These first authors contributed equally to this article.

Page created: December 02, 2021
Page updated: January 22, 2022
Page reviewed: January 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external